This week on The Dr. Randi Show, I sit down with Andrea Trofimuk, one of the most forward-thinking leaders shaping where aesthetics is heading next. Andrea leads North America for Sinclair North America, a global medical-aesthetics company recognized for its innovation and its portfolio spanning both injectables and energy-based devices.
We explore what matters now in aesthetics: skin health as a foundation, natural-looking results that feel authentic, personalized approaches that fit seamlessly into real life, and the growing influence of wellness and transparency on how people view beauty today. Andrea shares how education, social visibility, and evolving consumer expectations are reshaping the landscape, and why confidence, not perfection, has become the new benchmark.
If you’re looking to understand the forces driving the future of aesthetics and how beauty standards are evolving, this conversation delivers clarity, direction, and insight.
In this episode, we explore:
• The move toward subtle, elevated results that feel refined, not overdone
• How transparency on social media is transforming aesthetic culture
• The influence of wellness, longevity, and GLP-1 trends on beauty choices
• Why curated, combination approaches are becoming the new standard
• Andrea’s defining leadership moment, and how it fuels her vision today
Sponsored by NewBeauty💄
📱 Listen and Watch on Spotify: https://spti.fi/5I1CYKq
🎧 Listen Now on Apple: https://dub.link/WzpAq51
Episode FAQ
What does Sinclair do in the aesthetics industry, and what was this Dr. Randi Show episode about?
In this episode of The Dr. Randi Show, Andrea Trofimuk of Sinclair North America joined host Dr. Randi Boyette to talk about where the aesthetics industry is heading. Andrea explained that Sinclair has operated globally since 1971, starting as a pharmaceutical company before moving into aesthetic medicine and, by the late 2010s, injectables, where it became known for biostimulators, HA fillers, and threads. She described how Sinclair expanded into energy-based devices by acquiring Cocoon in 2021 and another energy-based device company in 2022 that gave it a foothold in North America. Today, she said, Sinclair works across both injectables and energy-based devices while building its brand and community in the United States.
Is a new biostimulator coming to the United States?
On The Dr. Randi Show, Andrea shared that Sinclair’s flagship biostimulator is now coming to the United States. She said the company has begun the FDA process and enrolled its first patients in June, and while she could not share timelines or further details, she framed it as an exciting step that will expand the portfolio beyond energy-based devices and into injectables. This reflects Andrea’s update on her company’s plans rather than a treatment recommendation.
How do energy-based devices support regenerative aesthetics?
Andrea explained on The Dr. Randi Show that energy-based devices are regenerative in nature because they use the body’s own processes to create results. She described how these devices can stimulate collagen and elastin and support lymphatic stimulation, allowing providers to prompt multiple biological responses. In her view, many practices already have regenerative aesthetics in their hands through the energy-based devices they own. This reflects Andrea’s perspective from the device side of the industry.
Why are combination or stackable treatments becoming more common in aesthetics?
On The Dr. Randi Show, Andrea described combination or stackable treatments as a major direction for the industry. She noted that the most credible physicians have combined treatments for decades, and that the approach is becoming mainstream as more providers adopt it. She tied this to what she calls holistic aesthetics, treating the whole patient across every age and life stage, and said advanced providers are increasingly performing several treatments in a single visit. Andrea framed it as being about the entire patient experience rather than a single injectable.
What aesthetic trends are shaping the future of the industry?
Andrea told The Dr. Randi Show that while looks move in cycles, from fuller and more defined to today’s more natural aesthetic, the lasting foundation is skin health. She said she expects peptides to keep entering the space, and that patients increasingly want reproducible, controllable results and multiple biological responses achieved in as little time as possible. She also pointed to regenerative treatments and stacked or combination procedures as continuing to rise. These are Andrea’s observations about where the market is moving.
How can patients and providers tell science-backed treatments from marketing hype?
On The Dr. Randi Show, Andrea suggested leaning on three kinds of intelligence. First, general intelligence and critical thinking to separate marketing claims from what is rooted in science. Second, emotional intelligence, so a decision is not made simply because someone likes a sales rep or an influencer. Third, aesthetic intelligence, meaning knowing enough about the space before making big decisions. Andrea also encouraged people to lean into a credible community and trusted sources, including podcasts, to understand what is a passing trend versus what is timeless. This reflects her personal advice.
How are patients and consumers shaping what aesthetic companies develop?
Andrea explained on The Dr. Randi Show that control in aesthetics has shifted over the decades from manufacturers to distributors to practices, and now to patients. She said today’s patients are savvier than ever and are dictating the results, experience, and frequency they want, which in turn shapes what manufacturers develop. She added that companies acting as both manufacturer and distributor can gather real-time feedback, including from social media, in a market with limited professional data sets. This is Andrea’s read on the industry dynamic.
How are wellness, longevity, and GLP-1 medications influencing aesthetics?
On The Dr. Randi Show, Andrea said wellness and longevity are increasingly overlapping with aesthetics, and that nothing prepared the industry for the speed and intensity of the shift brought by GLP-1 medications. She said this is pushing companies to accelerate research and development and to take a much broader view than before, rather than staying strictly within injectables or energy-based devices. Andrea framed it as a moment when the blinders are off for innovation across the space. These are her views on the trend.
How has social media openness changed the aesthetics industry?
Andrea observed on The Dr. Randi Show that aesthetics has moved from something people whispered about to something openly shared on social media, and that this exposure is driving major change. She noted that even in a mature market, only a fraction of potential patients have tried aesthetic services, so wider awareness supports growth. She said breaking down barriers around comfort, safety, and reproducible results will help reach more people, and that she is especially excited to see millennials, Gen Z, and more men enter the space. This reflects Andrea’s perspective.
What does confidence in aesthetics look like heading into 2026?
On The Dr. Randi Show, Andrea said she believes confidence in 2026 comes back to skin health and beauty from the inside. She described the industry as being less about appearance alone and more about how treatments make people feel, and encouraged people to do their homework, find the right treatments for their specific needs, and commit to a plan or series when one is recommended. She spoke about the emotional impact that treating a challenging area can have, drawing in part on her own journey. This reflects Andrea’s personal view rather than medical advice.
